PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma

Summary

The purpose of this study it to evaluate the efficacy of PTK787/ZK 222584, in inducing at least a 50% reduction in paraprotein in patients with multiple myeloma whose paraprotein levels are \< 5 g/dL following high dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT).

Timeline

Start

2005-09

Primary completion

2008-12

Completion

2008-12

Drugs

Indications